shopping cart Your cart is empty
  • Home
  • Healthcare
  • Vendor Neutral Archive (VNA) & PACS Market By Type Of Imaging Instruments (Magnetic Resonance Imaging, Utrasound, Nuclear Imaging,...

Vendor Neutral Archive (VNA) & PACS Market By Type Of Imaging Instruments (Magnetic Resonance Imaging, Utrasound, Nuclear Imaging, X Ray, Computed Tomography), By Delivery Mode (On-Site VNA, Fully Cloud-Hosted VNA, Hybrid VNA), By Vendors (Independent Software Vendors, Infrastructure Vendors), By Procurement (Multi-Departmental VNA, Multi-Site VNA, Departmental VNA), Components (Software And Services, Hardware), Industry Size, Growth, Share And Forecast To 2022

Published By: Brisk Insights | Published On: Jul 19, 2016

Key Findings


The global vendor neutral archive (VNA) & PACS market has been expected to grow at the CAGR of 7.2 % during 2016-2022 and is expected to reach $5700 million in terms of revenue till 2022.The vendor neutral archives (VNAs) are information technology platforms that allow long-term, single, standard-based and centralized storage of medical imaging studies and other patient data from multiple vendor PACS. On the other hand, picture archiving and communication system function as tools that directly connect to different imaging modalities in a facility by obtaining images from them.


The factors driving the vendor neutral archive & PACS market are increasing demand for disaster recovery, lifecycle management solutions and non-DICOM content management. New opportunities for the market lie in growth of VNAs through implementation of a patient-centric method. Though, factors such as misinterpretation of the VNA concept and long vendor neutral archives lifecycles acts as a barrier in the growth of the market. The dynamic factors of the global vendor neutral archive (VNA) & PACS market also include government initiatives that favor the use of advanced imaging information systems, technology and cost-related benefits and the need for centralized storage of standard-compliant imaging data. Apart from that, lack of an established definition of VNA resulting in confusion and data insecurity or breaches is an issue that hinders the growth of global vendor neutral archive (VNA) & PACS market. Fully cloud hosted VNAs, emerging markets, and patient-focused systems promises high-growth opportunities in the global vendor neutral archive (VNA) & PACS market.


Owing to the rising popularity of VNA solutions, the VNA market is presently in the growth phase of its product lifecycle. The market is categorized by several inter-firm partnerships to deliver the best-of-breed solutions to healthcare suppliers. Furthermore, development of products that enable the integration of VNAs with electronic health records (EHRs) and their consecutive launch in the market is a developing trend.


Market Segment Insight


Theglobal vendor neutral archive (VNA) & PACS market is majorly segmented intoimaging instruments, delivery mode, vendors, procurement, components and regional outlook.Imaging instruments segment is divided into magnetic resonance imaging, ultrasound, nuclear imaging, x ray, computed tomography and others. In imaging instruments segment magnetic resonance imaging is fastest and dominating segment. Delivery mode segment is divided into on site VNA, fully cloud hosted VNA and hybrid VNA.On site VNA segment is a leading segment among the market due to its improved data control and security. Though, high expenditure cost and availability of an alternate economical option of cloud hosted VNA are anticipated to hinder the global market growth for onsite VNA. Vendors segment is divided into independent software vendors and infrastructure vendors.Procurement segment is divided into multi departmental VNA, multi-site VNA and departmental VNA. components segment is divided into software and services and hardware. Software and services is subdivided into training services, consulting, implementation services and support & maintenance. Hardware segment is sub segmented into network devices, access devices, storage devices, peripherals and servers.Regional outlook is divided into North America, Europe, Asia Pacific and Rest of the World. North America is dominating the market. Rest of the world is showing slow growth rate. Europe and Asia Pacific is showing positive growth rate.


Regional Insight


Globally, the global vendor neutral archive (VNA) & PACS market is divided into North America, Europe, Asia Pacific and Rest of the World. North America is dominating the global vendor neutral archive (VNA) & PACS market. The large share is majorly due to meaningful use, the enterprise and state-wide installation of VNAs in Canada and a staged program for adoption of healthcare information systems that is a part of the HITECH Act (Healthcare Information Technology for Economical and Clinical Health Act) in the U.S. European region will witness strong growth due to the public-based healthcare system in most European countries that allows large scale and high-priced VNA contracts. The European region is growing at a very rapid rate in the forecasted period. Asia Pacific is also showing a positive growth. China, India and Japan are the major countries in Asia Pacific region. The major reason include state and nationwide healthcare IT policies in Japan and China. Rest of the world is showing sluggish growth rate. However, the PACS technology is now extensively adopted in the Middle East and Latin America.


Competitive Insights


Some ofthekey market players are ACUO Technologies (Perceptive software), Dejarnette Research Systems Inc., Carestream HealthInc., Dell Inc., AGFA Healthcare,Teramedica, Siemens Healthcare, Philips Healthcare, Novarad Corporation, Merge Healthcare, etc.Acquisitions, new product development, collaborations, joint ventures, mergers and expansions are the key strategies adopted by the market players to sustain in the market.

CHAP 1. METHODOLOGY & SCOPE 15
1.1. RESEARCH METHODOLOGY 15
1.2. RESEARCH SCOPE & ASSUMPTIONS 15
1.3. LIST OF DATA SOURCES 15


CHAP 2. EXECUTIVE SUMMARY 16
2.1. GLOBAL VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET SUMMARY & KEY BUYING CRITERIA 16
2.2. GLOBAL VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET OUTLOOK 16
2.3. MARKET SEGMENTATION ANALYSIS 16
2.4. MARKET SIZE AND GROWTH PROSPECTS 2012-2022 16
2.5. GLOBAL VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET VALUE CHAIN ANALYSIS 16
2.6. VENDOR LANDSCAPE 16


CHAP 3. GLOBAL VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET 17
3.1. MARKET DRIVER ANALYSIS 18
3.1.1. INCREASING DEMAND FOR STANDARD-BASED MEDICAL IMAGE ARCHIVING AND NON-DICOM CONTENT MANAGEMENT FUELS VNA DEPLOYMENTS 18
3.1.2. VNAS OVERCOME PACS TECHNOLOGICAL LIMITATIONS; ACT AS A MAJOR MARKET PROPELLANT 18
3.1.3. HEALTHCARE IT-SPECIFIC GOVERNMENT REGULATIONS AND GUIDELINES POSITIVELY IMPACT THE ADOPTION OF VNAS 18
3.1.4. REDUCTION OF DATA MIGRATION COSTS, A CRUCIAL BENEFIT OF A VNA, ENCOURAGES INVESTMENTS IN THE TECHNOLOGY 18
3.1.5. NEED FOR EFFECTIVE DISASTER RECOVERY AND LIFECYCLE MANAGEMENT STRATEGIES 18
3.2. MARKET RESTRAINT ANALYSIS 18
3.2.1. RISING INCIDENCES OF DATA BREACHES COMPROMISE PRIVACY AND SECURITY OF IMAGING DATA 18
3.2.2. LONGER VNA LIFECYCLES IMPACT THE ADOPTION DECISION OF PROVIDERS 18
3.2.3. UNCLEAR DEFINITION OF A TRUE VNA RESULT IN CONFUSION AMONG PROVIDERS 18
3.3. KEY OPPORTUNITIES 18
3.3.1. INCREASING INTEREST FROM EMERGING MARKET PROMOTES VNA TECHNOLOGY IN THESE REGIONS 18
3.3.2. CLOUD-BASED SOLUTIONS REPRESENT HIGH-GROWTH OPPORTUNITIES 18
3.3.3. PATIENT-CENTRIC APPROACH TO DELIVER ENHANCED CARE TO OPEN NEW AVENUES FOR DEVELOPMENT OF VNAS 18
3.4. CHALLENGES 18
3.4.1. SALE OF CASHLESS READERS TO MERCHANTS 18
3.4.2. LACK OF STANDARDIZATION AND CONSUMER AWARENESS 18


CHAP 4. INDUSTRY ANALYSIS 19
4.1. GLOBAL VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET– PORTER’S FIVE FORCE MODEL 19
4.2. GLOBAL VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET– PESTEL ANALYSIS 19
4.3. GLOBAL VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET– GAP ANALYSIS 19


CHAP 5. GLOBAL VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET BY TYPE OF IMAGING INSTRUMENTS 2012-2022 ($ MILLION) 20
5.1. GLOBAL VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET BY MAGNETIC RESONANCE IMAGING 2012-2022 ($ MILLION) 20
5.2. GLOBAL VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET BY UTRASOUND 2012-2022 ($ MILLION) 20
5.3. GLOBAL VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET BY NUCLEAR IMAGING 2012-2022 ($ MILLION) 20
5.4. GLOBAL VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET BY X RAY 2012-2022 ($ MILLION) 20
5.5. GLOBAL VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET BY COMPUTED TOMOGRAPHY 2012-2022 ($ MILLION) 20
5.6. GLOBAL VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET BY OTHERS 2012-2022 ($ MILLION) 20


CHAP 6. GLOBAL VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET BY DELIVERY MODE 2012-2022 ($ MILLION) 21
6.1. GLOBAL VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET BY ON-SITE VNA 2012-2022 ($ MILLION) 21
6.2. GLOBAL VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET BY FULLY CLOUD-HOSTED VNA 2012-2022 ($ MILLION) 21
6.3. GLOBAL VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET BY HYBRID VNA 2012-2022 ($ MILLION) 21


CHAP 7. GLOBAL VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET BY VENDORS 2012-2022 ($ MILLION) 22
7.1. GLOBAL VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET BY INDEPENDENT SOFTWARE VENDORS 2012-2022 ($ MILLION) 22
7.2. GLOBAL VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET BY INFRASTRUCTURE VENDORS 2012-2022 ($ MILLION) 22


CHAP 8. GLOBAL VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET BY PROCUREMENT 2012-2022 ($ MILLION) 23
8.1. GLOBAL VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET BY MULTI-DEPARTMENTAL VNA 2012-2022 ($ MILLION) 23
8.2. GLOBAL VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET BY MULTI-SITE VNA 2012-2022 ($ MILLION) 23
8.3. GLOBAL VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET BY DEPARTMENTAL VNA 2012-2022 ($ MILLION) 23


CHAP 9. GLOBAL VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET BY COMPONENTS 2012-2022 ($ MILLION) 24
9.1. GLOBAL VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET BY SOFTWARE AND SERVICES 2012-2022 ($ MILLION) 24
9.2. GLOBAL VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET BY HARDWARE 2012-2022 ($ MILLION) 24


CHAP 10. GLOBAL VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET REGIONAL OUTLOOK 2012-2022 ($ MILLION) 25
10.1. GLOBAL VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET BY REGION 2012-2022 ($ MILLION) 25
10.2. NORTH AMERICA 25
10.2.1. NORTH AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 25
10.2.2. NORTH AMERICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 25
10.2.3. NORTH AMERICA MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 25
10.2.3.1. U.S. 25
10.2.3.1.1. U.S. MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 25
10.2.3.1.2. U.S. MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 25
10.2.3.2. CANADA 25
10.2.3.2.1. CANADA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 25
10.2.3.2.2. CANADA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 25
10.2.3.3. MEXICO 25
10.2.3.3.1. MEXICO MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 25
10.2.3.3.2. MEXICO MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 25
10.3. EUROPE 26
10.3.1. EUROPE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 26
10.3.2. EUROPE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 26
10.3.3. EUROPE MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 26
10.3.3.1. GERMANY 26
10.3.3.1.1. GERMANY MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 26
10.3.3.1.2. GERMANY MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 26
10.3.3.2. UK 26
10.3.3.2.1. UK MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 26
10.3.3.2.2. UK MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 26
10.3.3.3. FRANCE 26
10.3.3.3.1. FRANCE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 26
10.3.3.3.2. FRANCE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 26
10.3.3.4. SPAIN 26
10.3.3.4.1. SPAIN MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 26
10.3.3.4.2. SPAIN MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 26
10.3.3.5. ITALY 26
10.3.3.5.1. ITALY MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 27
10.3.3.5.2. ITALY MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 27
10.3.3.6. REST OF EUROPE 27
10.3.3.6.1. REST OF EUROPE MARKET ESTIMATES AND FORECAST2012-2022($MILLION) 27
10.3.3.6.2. REST OF EUROPE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022($MILLION) 27
10.4. ASIA PACIFIC 27
10.4.1. ASIA PACIFIC MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 27
10.4.2. ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 27
10.4.3. ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 27
10.4.3.1. CHINA 27
10.4.3.1.1. CHINA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 27
10.4.3.1.2. CHINA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 27
10.4.3.2. INDIA 27
10.4.3.2.1. INDIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 27
10.4.3.2.2. INDIA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 27
10.4.3.3. JAPAN 27
10.4.3.3.1. JAPAN MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 27
10.4.3.3.2. JAPAN MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($MILLION) 27
10.4.3.4. SOUTH KOREA 27
10.4.3.4.1. SOUTH KOREA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 28
10.4.3.4.2. SOUTH KOREA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($MILLION) 28
10.4.3.5. REST OF APAC 28
10.4.3.5.1. REST OF APAC MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 28
10.4.3.5.2. REST OF APAC MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 28
10.5. REST OF THE WORLD 28
10.5.1. REST OF THE WORLD MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 28
10.5.2. REST OF THE WORLD MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 28
10.5.3. REST OF THE WORLD MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 28
10.5.3.1. LATIN AMERICA 28
10.5.3.1.1. LATIN AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 28
10.5.3.1.2. LATIN AMERICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 28
10.5.3.2. MIDDLE EAST AND AFRICA 28
10.5.3.2.1. MIDDLE EAST AND AFRICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 28
10.5.3.2.2. MIDDLE EAST AND AFRICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 28


CHAP 11. COMPETITIVE LANDSCAPE 29
11.1. ACUO TECHNOLOGIES (PERCEPTIVE SOFTWARE) 30
11.1.2. SCOT ANALYSIS 30
11.1.3. PRODUCT BENCHMARKING 30
11.1.4. STRATEGIC INITIATIVES 30
11.2. AGFA HEALTHCARE 30
11.2.2. SCOT ANALYSIS 30
11.2.3. PRODUCT BENCHMARKING 30
11.2.4. STRATEGIC INITIATIVES 30
11.3. BRIDGEHEAD SOFTWARE 30
11.3.2. SCOT ANALYSIS 30
11.3.3. PRODUCT BENCHMARKING 30
11.3.4. STRATEGIC INITIATIVES 30
11.4. CARESTREAM HEALTH INC. 30
11.4.2. PRODUCT BENCHMARKING 30
11.4.3. STRATEGIC INITIATIVES 30
11.5. DEJARNETTE RESEARCH SYSTEMS INC. 30
11.5.2. SCOT ANALYSIS 30
11.5.3. PRODUCT BENCHMARKING 30
11.5.4. STRATEGIC INITIATIVES 30
11.6. DELL INC. 30
11.6.2. SCOT ANALYSIS 30
11.6.3. PRODUCT BENCHMARKING 31
11.6.4. STRATEGIC INITIATIVES 31
11.7. FUJIFILM CORPORATION 31
11.7.2. SCOT ANALYSIS 31
11.7.3. PRODUCT BENCHMARKING 31
11.7.4. STRATEGIC INITIATIVES 31
11.8. GE HEALTHCARE 31
11.8.2. SCOT ANALYSIS 31
11.8.3. PRODUCT BENCHMARKING 31
11.8.4. STRATEGIC INITIATIVES 31
11.9. MACH 7 TECHNOLOGIES 31
11.9.2. SCOT ANALYSIS 31
11.9.3. PRODUCT BENCHMARKING 31
11.9.4. STRATEGIC INITIATIVES 31
11.10. MCKESSON CORPORATION 31
11.10.2. SCOT ANALYSIS 31
11.10.3. PRODUCT BENCHMARKING 31
11.10.4. STRATEGIC INITIATIVES 31
11.11. MERGE HEALTHCARE 31
11.11.2. SCOT ANALYSIS 31
11.11.3. PRODUCT BENCHMARKING 31
11.11.4. STRATEGIC INITIATIVES 31
11.12. NOVARAD CORPORATION 32
11.12.2. SCOT ANALYSIS 32
11.12.3. PRODUCT BENCHMARKING 32
11.12.4. STRATEGIC INITIATIVES 32
11.13. PHILIPS HEALTHCARE 32
11.13.2. SCOT ANALYSIS 32
11.13.3. PRODUCT BENCHMARKING 32
11.13.4. STRATEGIC INITIATIVES 32
11.14. SIEMENS HEALTHCARE 32
11.14.2. SCOT ANALYSIS 32
11.14.3. PRODUCT BENCHMARKING 32
11.14.4. STRATEGIC INITIATIVES 32
11.15. TERAMEDICA 32
11.15.2. SCOT ANALYSIS 32
11.15.3. PRODUCT BENCHMARKING 32
11.15.4. STRATEGIC INITIATIVES 32

TABLE 1 GLOBAL VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET BY TYPE OF IMAGING INSTRUMENTS 2012-2022 ($ MILLION) 32
TABLE 2 GLOBAL VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET BY MAGNETIC RESONANCE IMAGING 2012-2022 ($ MILLION) 32
TABLE 3 GLOBAL VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET BY UTRASOUND 2012-2022 ($ MILLION) 32
TABLE 4 GLOBAL VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET BY NUCLEAR IMAGING 2012-2022 ($ MILLION) 33
TABLE 5 GLOBAL VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET BY X RAY 2012-2022 ($ MILLION) 33
TABLE 6 GLOBAL VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET BY COMPUTED TOMOGRAPHY 2012-2022 ($ MILLION) 33
TABLE 7 GLOBAL VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET BY OTHERS 2012-2022 ($ MILLION) 33
TABLE 8 GLOBAL VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET BY DELIVERY MODE 2012-2022 ($ MILLION) 33
TABLE 9 GLOBAL VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET BY ON-SITE VNA 2012-2022 ($ MILLION) 33
TABLE 10 GLOBAL VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET BY FULLY CLOUD-HOSTED VNA 2012-2022 ($ MILLION) 33
TABLE 11 GLOBAL VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET BY HYBRID VNA 2012-2022 ($ MILLION) 33
TABLE 12 GLOBAL VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET BY VENDORS 2012-2022 ($ MILLION) 33
TABLE 13 GLOBAL VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET BY INDEPENDENT SOFTWARE VENDORS 2012-2022 ($ MILLION) 33
TABLE 14 GLOBAL VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET BY INFRASTRUCTURE VENDORS 2012-2022 ($ MILLION) 33
TABLE 15 GLOBAL VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET BY PROCUREMENT 2012-2022 ($ MILLION) 33
TABLE 16 GLOBAL VENDOR NEUTRAL ARCHIVE (VNA) MARKET & PACS MARKET BY MULTI-DEPARTMENTAL VNA 2012-2022 ($ MILLION) 33
TABLE 17 GLOBAL VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET BY MULTI-SITE VNA 2012-2022 ($ MILLION) 33
TABLE 18 GLOBAL VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET BY DEPARTMENTAL VNA 2012-2022 ($ MILLION) 33
TABLE 19 GLOBAL VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET BY COMPONENTS 2012-2022 ($ MILLION) 33
TABLE 20 GLOBAL VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET BY SOFTWARE AND SERVICES 2012-2022 ($ MILLION) 33
TABLE 21 GLOBAL VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET BY TRAINING SERVICES 2012-2022 ($ MILLION) 34
TABLE 22 GLOBAL VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET BY CONSULTING 2012-2022 ($ MILLION) 34
TABLE 23 GLOBAL VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET BY IMPLEMENTATION SERVICES 2012-2022 ($ MILLION) 34
TABLE 24 GLOBAL VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET BY SUPPORT & MAINTENANCE 2012-2022 ($ MILLION) 34
TABLE 25 GLOBAL VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET BY HARDWARE 2012-2022 ($ MILLION) 34
TABLE 26 GLOBAL VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET BY NETWORK DEVICES 2012-2022 ($ MILLION) 34
TABLE 27 GLOBAL VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET BY ACCESS DEVICES 2012-2022 ($ MILLION) 34
TABLE 28 GLOBAL VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET BY STORAGE DEVICES 2012-2022 ($ MILLION) 34
TABLE 29 GLOBAL VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET BY PERIPHERALS 2012-2022 ($ MILLION) 34
TABLE 30 GLOBAL VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET BY SERVERS 2012-2022 ($ MILLION) 34
TABLE 31 GLOBAL VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET REGIONAL OUTLOOK 2012-2022 ($ MILLION) 34
TABLE 32 GLOBAL VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET BY REGION 2012-2022 ($ MILLION) 34
TABLE 33 NORTH AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 34
TABLE 34 NORTH AMERICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 34
TABLE 35 NORTH AMERICA MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 34
TABLE 36 U.S. MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 34
TABLE 37 U.S. MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 34
TABLE 38 CANADA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 35
TABLE 39 CANADA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 35
TABLE 40 MEXICO MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 35
MEXICO MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 35
TABLE 41 35
TABLE 42 EUROPE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 35
TABLE 43 EUROPE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 35
TABLE 44 EUROPE MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 35
TABLE 45 GERMANY MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 35
TABLE 46 GERMANY MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 35
TABLE 47 UK MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 35
TABLE 48 UK MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 35
TABLE 49 FRANCE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 35
TABLE 50 FRANCE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 35
TABLE 51 SPAIN MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 35
TABLE 52 SPAIN MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 35
TABLE 53 ITALY MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 35
TABLE 54 ITALY MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 35
TABLE 55 REST OF EUROPE MARKET ESTIMATES AND FORECAST2012-2022 ($ MILLION) 36
TABLE 56 REST OF EUROPE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 36
TABLE 57 ASIA PACIFIC MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 36
TABLE 58 ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 36
TABLE 59 ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 36
TABLE 60 CHINA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 36
TABLE 61 CHINA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 36
TABLE 62 INDIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 36
TABLE 63 INDIA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 36
TABLE 64 JAPAN MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 36
TABLE 65 JAPAN MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 36
TABLE 66 SOUTH KOREA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 36
TABLE 67 SOUTH KOREA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 36
TABLE 68 REST OF APAC MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 36
TABLE 69 REST OF APAC MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 36
TABLE 70 REST OF THE WORLD MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 36
TABLE 71 REST OF THE WORLD MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 36
TABLE 72 REST OF THE WORLD MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 37
TABLE 73 LATIN AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 37
TABLE 74 LATIN AMERICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 37
TABLE 75 MIDDLE EAST AND AFRICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 37
TABLE 76 MIDDLE EAST AND AFRICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 37

FIGURE 1 NORTH AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 37
FIGURE 2 U.S. MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 37
FIGURE 3 CANADA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 37
FIGURE 4 MEXICO MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 37
FIGURE 5 EUROPE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 37
FIGURE 6 GERMANY MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 37
FIGURE 7 UK MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 37
FIGURE 8 FRANCE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 37
FIGURE 9 SPAIN MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 37
FIGURE 10 REST OF EUROPE MARKET ESTIMATES AND FORECAST2012-2022 ($ MILLION) 37
FIGURE 11 ASIA PACIFIC MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 38
FIGURE 12 CHINA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 38
FIGURE 13 INDIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 38
FIGURE 14 JAPAN MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 38
FIGURE 15 SOUTH KOREA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 38
FIGURE 16 REST OF APAC MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 38
FIGURE 17 REST OF THE WORLD MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 38
FIGURE 18 LATIN AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 38
FIGURE 19 MIDDLE EAST AND AFRICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 38

Choose License


Contact Information

: 24/7 Research Support

: sales@briskinsights.com

: +448081890034 (UK)